EPA NCER Cumulative Risk Assessment Webinar Series
The Cumulative Risk Assessment Webinar Series is a new monthly series of webinars presenting the latest research findings in cumulative risk assessment and impacts.
Our 1st webinar in this monthly series on August 29 will include a presentation called: "Non-Chemical Stressors and Cumulative Risk Assessment: An Overview of Current Issues and Initiatives".
We urge you to let your colleagues know about these webinars - there is no limit to the number of people that can participate in the webinar.
EPA's Risk Assessment Forum Cumulative Risk Assessment (CRA) Technical Panel is currently developing guidelines on CRA and EPA's National Center for Environmental Research is funding extramural research to advance the science further and introduce additional strategies for examining combinations of chemical, physical and biological stressors while factoring in population vulnerabilities.
Invited speakers in this series will present on a wide range of cumulative risk topics to inform participants about the development of the Agency's CRA Guidelines. The CRA Webinar Series will be presented monthly, and will be announced in two groupings, the first running through Dec. 2012, and the second to be announced in December 2012 and to run through December 2013.
UPCOMING WEBINAR:
"Nonchemical Stressors and Cumulative Risk Assessment: An Overview of Current Issues and Initiatives"
Speaker: Ari S. Lewis, M.S., Environmental Health Principal Scientist and Toxicology, Team Manager at Gradient - Environmental Consulting
Wednesday, August 29, 2012 from 3:00 p.m.-4:00 p.m. EDT
To register go to:
http://www.epa.gov/ncer/CRAwebinars What you will learn:
• Potential vulnerabilities in populations and their consideration in cumulative health risk assessment;
• Key facets of chemical risk assessment and how those issues inform efforts to advance the field of cumulative risk assessment, including consideration of the most significant challenges involved
with the incorporation of nonchemical stressors; and
• An overview of the research and approaches currently being explored to characterize cumulative risks, including mechanistic research, epidemiological evaluations and risk-ranking tools.
